A machine learning-driven framework accurately predicts MPA exposure and supports individualized dosing in childhood-onset LN.
Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk identification to improve prevention and management strategies. Traditional risk ...